AHA: Statins Cut Risk of MACE in Patients With ASCVD Event
Reduced frequency of MACE for patients receiving statins, especially high-intensity statins
XR Naltrexone, Sublingual BUP-NX Deemed Equally Effective
Difficulty initiating XR-NTX accounts for difference in relapse rates in intent-to-treat population
Findings Support Endovascular Repair of Aortic Aneurysm
Lower mortality at three years and gain in average QALY for endovascular versus open repair group
AHA: Noninvasive Testing Ups LOS in Patients With Chest Pain
Noninvasive testing with CCTA or stress testing also leads to more radiation exposure, greater cost
Health Care Experts in Favor of Patient Contribution to Notes
With some cautions, experts are supportive of the OurNotes medical notes intervention
FDA Approves Drug With Digital Ingestion Tracking System
Aripiprazole tablets have embedded sensors so patients, physicians can track medication ingestion
Outcomes for Atrial Fibrillation Similar With Dabigatran, Warfarin
Ischemic stroke, extracranial bleeding rates similar; lower risk of intracranial bleeding with dabigatran
More Laboratory Tests Performed at Major Teaching Hospitals
More tests per day for bacterial pneumonia, cellulitis at major teaching versus nonteaching hospitals
AAO: Higher Exercise Intensity Tied to Reduced Risk of Glaucoma
Risk reduced 73 percent for those with highest versus lowest level of self-reported activity
AHA/ACA Present New Blood Pressure Guidelines
New guidelines lower the diagnostic threshold for stage 1 hypertension to 130/80
